Jupiter Capex To Revenue from 2010 to 2024
| JUNS Stock | USD 9.73 1.13 10.41% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 298.9 K, Selling General Administrative of 2.8 M or Total Revenue of 199.5 K, as well as many indicators such as Price To Sales Ratio of 533, Dividend Yield of 0.0 or Days Sales Outstanding of 32.73. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
Jupiter | Capex To Revenue |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.